PharmaSynth AS

11044101

General info

Name

PharmaSynth AS

Registry code

11044101

VAT number

EE100940196

Type

AS - Joint Stock Company

Status

Registered

Foundation date

29.06.2004 (20)

Financial year

01.01-31.12

Capital

57 180.00 €

Activity

21201 - Manufacture of pharmaceutical preparations

Revenue

635 352 €

Profit

145 484 €

Profit margin

23%

Gross salary

2 726 €

(estimate is approximate)

Equity

896 244 €

Employees

7

Annual report

Submitted

Tax arrears

No tax arrears

Return on equity

16%

Return on assets

15%

Related parties

Owner Representative Beneficial owner Roles

Heli Väärtnõu-Järv

11.06.1959 (65)

11% - 6 180.00 EUR - - FounderBoard memberShareholder

SILLAMATSI MEDICAL OÜ

10913017

49% - 28 140.00 EUR - - FounderShareholder

Pirkko-Irene Penttilä-Hiltunen

11.01.1955 (69)

- Board member - Founder

Jukka Veli Hiltunen

10.11.1954 (70)

- - Direct ownership Founder

Olavi Loog

27.08.1969 (55)

- - - Board member

OÜ EDUSOFT

10769658

- - - Founder

Jaak Järv

05.11.1948 (76)

- - - FounderChairman of the board

Financial info

2019
05.10.2020
2020
05.08.2021
2021
02.03.2023
2022
21.06.2023
2023
26.06.2024
Total Revenue 319 371 € 444 406 € 510 772 € 475 618 € 635 352 €
Net profit (loss) for the period 42 880 € 199 141 € 247 819 € 121 436 € 145 484 €
Profit Margin 13% 45% 49% 26% 23%
Current Assets 213 484 € 398 964 € 588 770 € 635 684 € 783 422 €
Fixed Assets 25 598 € 38 269 € 90 310 € 197 667 € 157 357 €
Total Assets 239 082 € 437 233 € 679 080 € 833 351 € 940 779 €
Current Liabilities 45 479 € 55 728 € 49 756 € 82 591 € 44 535 €
Non Current Liabilities 11 239 € 0 € - - -
Total Liabilities 56 718 € - - - -
Share Capital 60 908 € 60 908 € 60 908 € 60 908 € 57 180 €
Equity 182 364 € 381 505 € 629 324 € 750 760 € 896 244 €
Employees 8 7 7 7 7

Paid taxes, taxable turnover and number of employees

Turnover
State taxes
Labor taxes and payments
Employees
2024 Q1 139 706.86 € 31 247.92 € 32 989.43 € 8
2023 Q4 74 760 € 30 655.78 € 32 095.88 € 8
2023 Q3 189 319.51 € 30 190.54 € 31 856.61 € 8
2023 Q2 144 446.36 € 34 124.62 € 36 060.7 € 8
2023 Q1 194 810.66 € 30 068.21 € 31 743.36 € 8
2022 Q4 136 055.56 € 24 294.54 € 25 555.64 € 8
2022 Q3 108 932.07 € 19 035.63 € 19 929.45 € 8
2022 Q2 112 649.3 € 16 704.07 € 15 587.78 € 8
2022 Q1 96 840.74 € 19 011.71 € 20 014.68 € 7
2021 Q4 146 515.77 € 16 656.35 € 17 566.97 € 8
2021 Q3 109 604.25 € 16 646.19 € 17 671.99 € 8
2021 Q2 137 043.77 € 14 379.25 € 15 141.82 € 8
2021 Q1 137 042.39 € 20 087.77 € 21 365.31 € 8
2020 Q4 58 124.73 € 11 993 € 12 792.19 € 8
2020 Q3 82 335 € 11 905.82 € 12 671.89 € 8
2020 Q2 70 810.61 € 11 233.75 € 11 943.8 € 7
2020 Q1 144 400.94 € 19 608.94 € 19 640.49 € 7